ESAB raises 2025 guidance as Q3 sales rise 8% to $728 million; GAAP EPS falls
ESAB reported third-quarter 2025 sales of $728 million, up 8% on a reported basis and 2% on a core organic basis, and completed the EWM acquisition. Diluted EPS from continuing operations was $1.04, down from $1.13 a year earlier, while core adjusted EPS rose to $1.32 from $1.25. The company raised its full-year 2025 core sales growth and core adjusted EBITDA outlook, which matters to shareholders because it changes the company's expected full-year results.
Key points
- Q3 sales $728 million, up 8% reported and 2% core organic; net income from continuing operations attributable to ESAB $64 million
- Diluted EPS $1.04 versus $1.13 a year earlier; core adjusted diluted EPS $1.32 versus $1.25
- 2025 core sales growth outlook raised to 4.5%-5.5% from 1.5%-3.5%; core adjusted EBITDA outlook raised to $535-$540 million from $525-$535 million
- Core adjusted EPS outlook narrowed to $5.20-$5.30 from $5.15-$5.30
The filing
Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.